hydantoins has been researched along with Atherosclerotic Parkinsonism in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Meltzer, LT; Schelkun, RM; Serpa, K; Whittemore, ER; Wise, LD; Woodward, RM; Yuen, PW | 1 |
| Bauer, H | 1 |
| Guelfi, JD; Pichot, P; Samuel-Lajeunesse, B | 1 |
1 review(s) available for hydantoins and Atherosclerotic Parkinsonism
| Article | Year |
|---|---|
[Drug induced functional disorders of the tongue, pharynx and larynx].
Topics: Adult; Androgens; Barbiturates; Child; Extrapyramidal Tracts; Female; Hirsutism; Humans; Hydantoins; Laryngeal Diseases; Movement Disorders; Parkinson Disease, Secondary; Pharyngeal Diseases; Tongue Diseases; Tranquilizing Agents; Virilism | 1967 |
2 other study(ies) available for hydantoins and Atherosclerotic Parkinsonism
| Article | Year |
|---|---|
Subtype-selective N-methyl-D-aspartate receptor antagonists: benzimidazalone and hydantoin as phenol replacements.
Topics: Animals; Benzimidazoles; Electrophysiology; Excitatory Amino Acid Antagonists; Hydantoins; Hydrogen Bonding; Male; Neuroprotective Agents; Oocytes; Oxidopamine; Parkinson Disease, Secondary; Piperidines; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; RNA, Messenger; Sympatholytics; Xenopus | 2000 |
[Etiologic problems posed by a catatonic syndrome].
Topics: Adolescent; Catatonia; Encephalitis; Epilepsy; Female; Humans; Hydantoins; Parkinson Disease, Secondary; Scarlet Fever; Tranquilizing Agents | 1969 |